Brief: Pledpharma To Initiate One Pivotal Phase II/III Study With Aladote

Egetis Therapeutics AB (publ)

08/01/2020 07:08

Jan 8 (Reuters) - PledPharma AB (publ)  PLED.ST :
    * TO INITIATE ONE PIVOTAL PHASE II/III STUDY WITH ALADOTE®
FOR
MARKETING AUTHORISATION APPLICATION IN BOTH US AND EU
    * STUDY IS PLANNED TO BE INITIATED MID-2020

Source text for Eikon:  ID:nNDL9CBFmh 
Further company coverage:  PLED.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))